Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Behandling av bipolar lidelse under svangerskap og etter födsel
Engelsk titel: Treatment of bipolar disorder during pregnancy and in the postpartum period Läs online Författare: Berle, Jan Öystein ; Solberg, Dag Kristen ; Spigset, Olav Språk: Nor Antal referenser: 31 Dokumenttyp: Översikt UI-nummer: 11021582

Tidskrift

Tidsskrift for Den Norske Laegeforening 2011;131(2)126-9 ISSN 0029-2001 E-ISSN 0807-7096 KIBs bestånd av denna tidskrift

Sammanfattning

Background. Pharmacological treatment and prophylaxis of bipolar disorders during pregnancy and in the postpartum period imply complicated clinical assessments. Material and method. This article is based on a non-systematic search in PubMed and the authors’ clinical experience. Results. If a woman is already using a prophylactic drug at the time of pregnancy, she can in general continue to do so during pregnancy, with the exception of valproate. If the disorder starts during pregnancy; lithium, lamotrigine or second generation antipsychotic drugs are suitable alternatives. In general, drugs used during pregnancy can also be used in the postpartum period, although some require special precautions if the mother wishes to breast-feed. If treatment is initiated after delivery, the mother’s wish to breast-feed should be taken into consideration when choosing a drug. Interpretation. Although existing studies have weaknesses, there is sufficient evidence to give qualified advice regarding choice of medication for bipolar disorder during pregnancy and in the postpartum period.